Compare TKO Group Holdings Inc (TKO) vs TransMedics Group Inc (TMDX) Price & Performance

TKO trades at $181.63, up 1.67% today, but technical indicators signal a bearish trend with the current price near support at $180. The stock recently hit a 52-week low of $174.58 (Defense World, 2026-10-02), reflecting near-term pressure. Fundamentally, revenue grew to $5.3B in 2026 with a net profit margin of 4.32%, though the Q2 2026 EPS of $1.34 missed expectations. A quarterly dividend of $0.79 was declared for payment on September 30, 2026.

The outlook is mixed: strong analyst consensus (89% buy ratings) and a $227 price target suggest upside, but bearish technicals and recent earnings misses pose risks. Key opportunities include media rights growth from UFC and WWE, while execution on guidance and competitive pressures are critical watchpoints for investors.

TransMedics Group (TMDX) trades at $79.00, down 2.55% amid bearish technical signals and mixed earnings performance. The stock shows strong fundamentals with 58.69% gross margins and 22.69% net income margins, though profitability declined year-over-year. Recent news highlights insider buying, CFO appointment, and ongoing legal investigations into fiduciary duties, creating conflicting sentiment signals.

While analyst consensus remains bullish with a $99.75 price target, near-term risks include margin pressure from heavy investments and legal uncertainties. The stock's current valuation at 20.47 P/E offers potential upside if execution improves, but investors face volatility from earnings misses and regulatory scrutiny.